Reversing a trend in which contributions from drugmakers’ political committees and their employees have gone largely to Republicans, so far for 2020 the industry has tilted toward Democrats.
The Trump administration has increasingly pinned its coronavirus testing strategy for the nation on tests that are not the most accurate.
Ever since he was a presidential candidate, President Donald Trump has been promising the American people a “terrific,” “phenomenal” and “fantastic” new health care plan to replace the Affordable Care Act.
During the 2020 State of the Union address, President Donald Trump zeroed in on prescription drug prices, arguing that his administration is “taking on the big pharmaceutical companies.”
Polls say health care is consistently at the top of voters’ minds in this election cycle. And President Donald Trump clearly wants to own the issue, often talking about the “wins” stemming from his administration’s policies.
Far more Americans disapprove of President Donald Trump’s handling of several high-profile health care issues than give him positive marks, underscoring the challenge the president faces in claiming health care as a political asset in his reelection bid.
With the 2020 election months away, President Donald Trump’s reelection campaign is touting his health care record as a key reason voters should grant him another term.
On his first day in office, as part of his mission to dismantle the Affordable Care Act, President Donald Trump signed an order
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Health insurers in Oregon and nationally are pushing back against a Trump administration decision affecting a key piece of the Affordable Care Act.
